Literature DB >> 21384050

Solution studies of dinuclear polyamine-linked platinum-based antitumour complexes.

Rasha A Ruhayel1, Ibrahim Zgani, Susan J Berners-Price, Nicholas P Farrell.   

Abstract

The aquation profiles of two novel dinuclear polyamine-linked, platinum-based antitumour complexes [{trans-PtCl((15)NH(3))(2)}(2){μ-((15)NH(2)(CH(2))(6)(15)NH(2)(CH(2))(6)(15)NH(2))}](3+) (BBR3007, 1,1/t,t-6,6, 1) and [{trans-PtCl((15)NH(3))(2)}(2){μ-((15)NH(2)(CH(2))(6)(15)NH(2)(CH(2))(2)(15)NH(2)(CH(2))(6)(15)NH(2))}](4+) (BBR3610, 1,1/t,t-6,2,6, 1') have been probed using 2D [(1)H, (15)N] HSQC NMR spectroscopy. Reported herein are the rate constants for the hydrolysis of 1 and 1', as well as the acid dissociation constants of the coordinated aqua ligands in their aquated derivatives. The aquation and anation rate constants for the single step aquation model in 15 mM NaClO(4) (pH 5.4) at 298 K are, for 1, k(1) = 7.2 ± 0.1 ×10(-5) s(-1), k(-1) = 0.096 ± 0.002 M(-1) s(-1) and, for 1', k(1) = 4.0 ± 0.2 × 10(-5) s(-1), k(-1) = 1.4 ± 0.1 M(-1) s(-1). The effect of the linker backbone (Pt(tetra(m)mine vs. polyamine) was evaluated by comparison with previous data for the trinuclear complex [{trans-PtCl(NH(3))(2)}(2)(μ-trans-Pt(NH(3))(2){NH(2)(CH(2))(6)NH(2)}(2))](4+) (1,0,1/t,t,t or BBR3464). The pK(1) for 1,0,1/t,t,t (3.44) is closest to that of 1 (3.12), while the pronounced difference for 1' (4.54), means that 1' is the least aquated of the three complexes at equilibrium. pK(a) values of 5.92 were calculated for the aquated forms of both 1 and 1', which are 0.3 pK units higher than for either 1,0,1/t,t,t, or the dinuclear 1,1/t,t. The higher pK(a) values for both polyamine-linked compounds may be attributed to the formation of macrochelates between the central NH(2) groups and the {PtN(3)O} coordination sphere of the aquated species.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21384050      PMCID: PMC3341406          DOI: 10.1039/c1dt00001b

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  32 in total

Review 1.  Polynuclear platinum drugs.

Authors:  Nicholas Farrell
Journal:  Met Ions Biol Syst       Date:  2004

2.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

3.  A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464.

Authors:  Tracey D McGregor; Alexander Hegmans; Jana Kaspárková; Kamila Neplechová; Olga Nováková; Hana Penazová; Oldrich Vrána; Viktor Brabec; Nicholas Farrell
Journal:  J Biol Inorg Chem       Date:  2002-01-08       Impact factor: 3.358

4.  Kinetic and equilibria studies of the aquation of the trinuclear platinum phase II anticancer agent [(trans-PtCl(NH(3))(2))(2)(mu-trans-Pt(NH(3))(2)(NH(2)(CH(2))(6)NH(2))(2))](4+) (BBR3464).

Authors:  Murray S Davies; Donald S Thomas; Alexander Hegmans; Susan J Berners-Price; Nicholas Farrell
Journal:  Inorg Chem       Date:  2002-03-11       Impact factor: 5.165

5.  Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.

Authors:  Alexander Hegmans; Susan J Berners-Price; Murray S Davies; Donald S Thomas; Anthony S Humphreys; Nicholas Farrell
Journal:  J Am Chem Soc       Date:  2004-02-25       Impact factor: 15.419

6.  Determination of protonation sites in thermospermine and in some other polyamines by 15N and 13C nuclear magnetic resonance spectroscopy.

Authors:  Y Takeda; K Samejima; K Nagano; M Watanabe; H Sugeta; Y Kyogoku
Journal:  Eur J Biochem       Date:  1983-02-01

7.  Interactions between natural polyamines and tRNA: an 15N NMR analysis.

Authors:  L Frydman; P C Rossomando; V Frydman; C O Fernandez; B Frydman; K Samejima
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

8.  Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma.

Authors:  D I Jodrell; T R J Evans; W Steward; D Cameron; J Prendiville; C Aschele; C Noberasco; M Lind; J Carmichael; N Dobbs; G Camboni; B Gatti; F De Braud
Journal:  Eur J Cancer       Date:  2004-08       Impact factor: 9.162

9.  Equilibrium and kinetic studies of the aquation of the dinuclear platinum complex [[trans-PtCl(NH3)2]2(mu-NH2(CH2)6NH2)]2+: pKa determinations of aqua ligands via [1H,15N] NMR spectroscopy.

Authors:  M S Davies; J W Cox; S J Berners-Price; W Barklage; Y Qu; N Farrell
Journal:  Inorg Chem       Date:  2000-04-17       Impact factor: 5.165

10.  Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H-15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy.

Authors:  Michael E Oehlsen; Yun Qu; Nicholas Farrell
Journal:  Inorg Chem       Date:  2003-09-08       Impact factor: 5.165

View more
  3 in total

1.  Ligand modulation of a dinuclear platinum compound leads to mechanistic differences in cell cycle progression and arrest.

Authors:  Vijay R Menon; Erica J Peterson; Kristoffer Valerie; Nicholas P Farrell; Lawrence F Povirk
Journal:  Biochem Pharmacol       Date:  2013-10-24       Impact factor: 5.858

2.  Investigations of the binding of [Pt2(DTBPA)Cl2](II) and [Pt2(TPXA)Cl2](II) to DNA via various cross-linking modes.

Authors:  Hongwei Yue; Bo Yang; Yan Wang; Guangju Chen
Journal:  Int J Mol Sci       Date:  2013-09-26       Impact factor: 5.923

3.  Insights into the κ-P,N Coordination of 1,3,5-Triaza-7-phosphaadamantane and Derivatives: κ-P,N-Heterometallic Complexes and a 15N Nuclear Magnetic Resonance Survey.

Authors:  Andrés Alguacil; Franco Scalambra; Antonio Romerosa
Journal:  Inorg Chem       Date:  2022-04-04       Impact factor: 5.436

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.